chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Received first dose Pfizer (LOT# EW0150) on 4/02/21. Pt raised hand and stated to EMT that she had pain in her chest, shoulders, back/neck and down both of her arms 4-5/10 on pain scale. Pt stated that she started feeling dizzy with blurry vision and a tight feeling in her head. EMT moved pt to gravity chair. Pt progressively got weaker and more drowsy. PHN offered pt EMS. Pt declined EMS. PHN recommended EMS to be called. Pt agreed for EMS to be called. EMT took pt vital signs at 1317. BP: 124/76, HR: 78. EMS arrived on scene at 1325 and took over. Pt left vaccination site via gurney with paramedic. Pt was transported and left in ambulance at 1335.
LEFT FACIAL PALSY 3/30/2023 ALCOHOLIC CIRRHOSIS ACUTE LACUNAR STROKE, UNSPECIFIED TYPE AND ARTERY 3/29/2023 ALCOHOLIC CIRRHOSIS ACUTE STROKE DUE TO ISCHEMIA, UNSPECIFIED TYPE AND ARTERY 3/31/2023 ALCOHOLIC CIRRHOSIS  LEFT FACIAL MUSCLE WEAKNESS 3/29/2023 ALCOHOLIC CIRRHOSIS
developed a migraine; nausea; sensitivity to light and sound; sensitivity to light and sound; she developed significant loss of mental clarity (brain fog); On 18Dec in the AM, developed progressive severe soreness at injection site, worse than any other vaccine, hurt even just the the touch. This lasted about a total of 36 hours and progressively improve; brain fog; retroorbital headache/intermittent mild tension type frontal headache; This is a spontaneous report from a contactable physician (patient).  A 29-year-old female patient received first dose BNT162B2 (lot number EH9899), via an unspecified route of administration on 17Dec2020 12:00 at 29 years old at single dose at Left arm for COVID-19 immunization.  Medical history included Mirena IUD, personal and family history of retinal migraines (without headache). The concomitant medications were magnesium citrate, melatonin, ademetionine (SAME) and fish oil. On 18Dec2020 in the AM, developed progressive severe soreness at injection site, worse than any other vaccine, hurt even just the touch. This lasted about a total of 36 hours and progressively improved. There was no swelling, redness, or other local symptoms. In the afternoon on 18Dec2020, she developed significant loss of mental clarity (brain fog) while at work. In the evening on 18Dec2020, developed mild retroorbital headache (this was actually the first headache of my life). All day 19Dec2020 and about half the day of 20Dec2020 developed a migraine (also the first of my life), experienced as retroorbital pounding headache, sensitivity to light and sound in 19Dec2020, nausea without vomiting in 19Dec2020, and loss of mental clarity. She had intermittent mild tension type frontal headache on 20Dec2020 PM with all other symptoms resolved, all symptoms resolved by 21Dec2020 AM. The patient used naproxen 440 mg and Tylenol 1000 mg on 19Dec2020. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient was not Allergic to medications, food, or other products. The outcome of the events was recovered on 21Dec2020.  The information on the batch number has been requested.; Sender's Comments: Based on information available, the reported loss of mental clarity together with other events was likely related to the first dose BNT162B2 due to temporal relationship and clinical course.  The case will be reassessed should additional information become available.  The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Regulatory Authorities, Ethics Committees and Investigators, as appropriate.
approx 7 days p/vax pt seen in office; mom reported that pt had been vomiting 2 days had a runny nose but afebrile; upon exam pt also had sterile abscess @ inject site; 9JUN abscess drained spontaneously drainage was purulent; pt recovered;
This spontaneous report was received from a pharmacist, concerning a patient of unknown age and gender. The patient's pertinent medical history, drug reactions/allergies were not provided. On 19-JUL-2013 the patient received a dose of PNEUMOVAX23 vial, (dose, route, lot number and expiration date were not provided). Co-suspect therapy and concomitant medications were not provided. It was reported that on 01-AUG-2013, the patient received another dose of PNEUMOVAX23 (dose, route, lot number and expiration date were not provided). No adverse effects were reported. Additional information has been requested.
Pt felt fine but developed a rash on hands, legs, arms and torso within 15 minutes. Per MD order pt was given IM BENADRYL 50 mg. 12:30 IM BENADRYL given in right deltoid 50 mg/ml Baxter Lot 117068, exp. 11/2009. Pt has small, pink rash on body, itching decreased, feeling sleepy, no difficulty breathing. Alert and oriented with partner. 12:45 Doing well, sleepy, note faxed to work for release from work today. 13:00 Discharged to home with partner and instructions.
Patient had a reaction to PNEUMOVAX at injection site. Pt said there was hardness around injection site and a lot of discomfort.
Stomach pain; Dizzy; Nauseous; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN UPPER (Stomach pain), DIZZINESS (Dizzy) and NAUSEA (Nauseous) in an 86-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 05UE211A) for COVID-19 vaccination.     The patient's past medical history included Hypothyroidism. Concurrent medical conditions included Penicillin allergy, Allergy to antibiotic and Drug allergy. Concomitant products included LEVOTHYROXINE for an unknown indication.    On 12-Sep-2021, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In September 2021, the patient experienced ABDOMINAL PAIN UPPER (Stomach pain), DIZZINESS (Dizzy) and NAUSEA (Nauseous). At the time of the report, ABDOMINAL PAIN UPPER (Stomach pain), DIZZINESS (Dizzy) and NAUSEA (Nauseous) had resolved.            No Treatment medication information was provided.
Received Expired dose of vaccine; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Received Expired dose of vaccine) in a 31-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-May-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-May-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (Received Expired dose of vaccine). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Received Expired dose of vaccine) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No relevant concomitant medications reported.  No treatment information was provided. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.
Blood clots; Tiny dots are showing up on arm of injection site; One larger dot on breast; Cold feeling in arm; This spontaneous case was reported by a consumer and describes the occurrence of THROMBOSIS (Blood clots) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced THROMBOSIS (Blood clots) (seriousness criterion medically significant), VACCINATION SITE DISCOLOURATION (Tiny dots are showing up on arm of injection site), BREAST DISCOLOURATION (One larger dot on breast) and PERIPHERAL COLDNESS (Cold feeling in arm). At the time of the report, THROMBOSIS (Blood clots), VACCINATION SITE DISCOLOURATION (Tiny dots are showing up on arm of injection site), BREAST DISCOLOURATION (One larger dot on breast) and PERIPHERAL COLDNESS (Cold feeling in arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported. Treatment information in response to events was not provided.   Company Comment   Very limited information regarding this events has been provided at this time.  Further information has been requested.; Sender's Comments: Very limited information regarding this events has been provided at this time.  Further information has been requested.
Vaccine given about 4pm 5.1.06 to healthy child. Parents report he came to their bed with fever and headache after midnight. At 7:30 a.m. emesis and then twice more before 2:00 p.m. 5.2.06. By noon fever was 103. At office visit 2:50 p.m. temperature was 102.4; Tylenol given. He looked tired but physical exam was otherwise WNL.
Vaccine was drawn up and administered. Afterwards when logging vaccine was noted that dose had expired in May 2017.
Developed herpes zoster like rash on right abdomen/flank after receiving Varicella/MMR on 03/24/04.
Severe brain fog and headaches. I feel like I can't relax. It's like someone is lightly squeezing my brain all the time and I'm only getting 5 hours of sleep every night.
This spontaneous report as received from a pharmacist via a field employee refers to 2 unspecified patients of unknown age and gender. Pertinent medical history, drug reactions or allergies were not reported. On an unknown date, the patients were vaccinated with ZOSTAVAX (dose, route and lot number were not reported). Concomitant medication was not reported. On an unknown date, reported as "2 to 3 days later", the patient developed diarrhea and an "upset" stomach. The pharmacist stated that both patients received the ZOSTAVAX in the pharmacy and the patients reported the reaction to the pharmacist during a "follow up" phone call "2 to 3 days" after receiving the ZOSTAVAX. The outcome of developing diarrhea and an upset stomach was unknown. Causality was not reported. Additional information has been requested.
She developed a high fever of 104, became limp, and was not responsive. We tried to administer Infant Tylenol (3.75 ml), but she vomited. We rushed to ER at that point and by the time we got there she was more alert and they brought the fever down with Ibuprofen. She continued to have high fever for three days and was struggling with motor skills previously mastered (brining toys to her mouth, grasping, holding our fingers). She is starting to come down from fever today (11/6/15) and seems to be regaining her skills and has begun to act more like herself.
Initial and follow up information has been received from a  medical assistant and a physician concerning a 65 year old female violin teacher who is well nourished, well developed, and well groomed and has a good build, with allergies to erythromycin (rash), penicillin (swelling), and sulfa drugs (rash), non smoker, and a history of De Quevain's tenosynovitis, Dupuytren's  contracture (right fifth digit), a mammogram 6/10/05, colonoscopy 8/2003 not complete, and a core biopsy 9/04 and non contributory family history, who on 6/22/05 at 11:14 was vaccianted intramuscularly into the left deltoid muscle with a 0.5ml dose of Pneumococcal 23v polysaccharide vaccine (lot 649913/0577P). Concomitant therapy included calcium carbonate, vitamins unspecified, amitriptyline HCL and estradiol Estrace. On 6/22/05, the patient went home and started noticing redness and swelling around the site that had continued to extend. on 6/23/05, the patient stated that she had an allergic reaction to the vaccine given yesterday. She complained of skin problems which included significant erythema, swelling and pain covering a large portion of her upper arm. Her body temperature measurement was 99.2 deg F and her pulse was 102 and regular. It was also noted that new lesions and skin color charges were present. The patient was diagnosed with cellulitis of the arm specifically the axilla. The patient was advised to use cool packs periodically and do her best to keep her arm elevated. She was treated with Azithromycin Zithromax 250 mg tablet QD, 1 tablet a day, 2 tablets to be taken on day 1 and methylprednisolone Medrol, 4mg tablet QD. The patient will return to the office on 6/24/05 for follow up. It was noted that the risk of complications was moderate. AT the time of this report, the patient had not recovered from cellulitis. On 7/5/05, the patient stated that she has pain on her left thumb, possibly tendonitis. The patient had taken Ibuprofen Advil and diphenhydramine hydrochloride Benadryl. It was noted that NSAID not specified dose of 600mg. She did this and her symptoms improved. The patient was concerned because she had swelling around the proximal thumb and was afraid of osteomyelitis. It was noted that the patient felt well in general but she had wrist and hand pain and joint redness, swelling and tenderness over the left metacarpal bone. She was diagnosed with tendonitis. The patient was advised to continue with NSAIDS and if there was no improvement then she should see a hand surgeon. Lab test included a blood platelet count, a serum C reactive protein test, a serum rheumatoid factor test, a complete blood cell count, and erythrocyte sedimentation rate (results not reported). The risk of complication were moderate. It was noted that the patient used to have a egg allergy but has received influenza vaccines without problems as an adult. No product quality complaint was involved. Additional information has been requested.
Cold symptoms; arm is hot, face was very hot; sore at injection site; Light headed; Sore; A spontaneous report was received from a consumer concerning herself, a 68-years-old female patient, who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced light headed/dizziness, sore/pain, cold symptoms/nasopharyngitis, arm and face hot/hot flushes, sore at the injection site/vaccination site pain.  The patient's medical history was not included . Concomitant products was not included.  On 13 Feb 2021, prior to the onset of event the patient received first dose of their two planned doses of mRNA-1273 (Batch N0:not provided) in the left arm for prophylaxis of covid 19 infection.  On 13 Feb 2021 the patient experienced light headed, and sore. On 21 Feb 2021 she began experiencing cold symptoms, arm is hot and sore at injection site. Face was very hot.  Treatment information was not included.   Action taken with mRNA-1273 in response to the events was not provided.   The outcome of the events, light headed/dizziness, sore/pain were resolved on 13 Feb 2021, the outcome of the events, cold symptoms/nasopharyngitis, arm and face hot/hot flushes, sore at the injection site/vaccination site pain were resolved on 22 Feb 2021.
Vertigo 90 minutes after vaccination and still present; also has headache, fatigue, and chest pain; slight transaminitis; no fever, mental status changes, abdominal pain.
Patient received the 1st dose of the Pfizer Vaccine and experienced a syncopal event causing dizziness soon after receiving the vaccine. The pharmacist responded immediately and emergency medical services were contacted immediately. The patient was standing at the time symptoms began and dizziness caused the patient to fall over. The patient was guided to a chair and the pharmacist took the patients blood pressure which was approximately 90/60. The patient did not exhibit any signs of difficulty breathing and was alert after sitting down. The patient had a small cut on their left thigh from falling over. The pharmacist cleaned the cut and bandaged it then retook the patients blood pressure after about 5 minutes. At that time the patients blood pressure had returned to normal (approximately 125/70) and the patient was feeling fine. Emergency medical services arrived and the patient was able to walk outside to the ambulance. EMS retook the patients blood pressure again and the results were normal and consistent with the second reading taken by the pharmacist. The patient felt normal and did not require any additional emergency medical services at the time. The patient was contacted approximately 2 hours after the adverse event and still reported feeling fine and was being monitored by his parents at home. The patient was instructed to contact EMS should any symptoms occur after going home.
Booster shot was administered to a 6-weeks pregnant woman, and 4 days later she had a miscarriage. Woman had no history of miscarriages, has a 3-year old healthy child born naturally. There is no direct evidence that miscarriage was caused by the vaccination, however, this report is needed for completeness of the scientific data.
Patient reported additional swelling outside of the left deltoid. The swelling began to extend down into his front breast and side of chest. Patient noticed this the next day after his vaccination. Reported no other changes in BP, HR, dizziness, itching or flu symptoms, but was concerned about the large area of swelling. Informed to use an ice pack to reduce swelling and take BENADRYL to help as well. Warned if continued swelling or changes in BP/HR or dizziness to go to ER.
Redness, swelling and pain all down left side at shoulder, chest, forearm, back of waist, groin, above knee cap and foot.
Right arm red from arm to neck with a break in between, right arm redness between elbow and top of arm; Itching; Right arm being painful; Chills; Headache; Fatigue; Fever of 102.6 degrees for 24 hours/ low grade fever for 24 hours; This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (Right arm red from arm to neck with a break in between, right arm redness between elbow and top of arm), PRURITUS, MYALGIA (Right arm), CHILLS, and HEADACHE in a 91-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was reported by the reporter.  Concomitant products included GABAPENTIN, ATORVASTATIN, METOPROLOL, CALCITRIOL, and ASPIRIN for an unknown indication.   On 26-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 23-Apr-2021, the patient experienced ERYTHEMA (Right arm red from arm to neck with a break in between, right arm redness between elbow and top of arm), PRURITUS, MYALGIA (Right arm being painful), CHILLS, HEADACHE, FATIGUE, and PYREXIA (Fever of 102.6 degrees for 24 hours/ low grade fever for 24 hours). On 24-Apr-2021, PYREXIA (Fever of 102.6 degrees for 24 hours/ low grade fever for 24 hours) had resolved. At the time of the report, ERYTHEMA (Right arm red from arm to neck with a break in between, right arm redness between elbow and top of arm), PRURITUS, MYALGIA, CHILLS, HEADACHE, and FATIGUE outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Apr-2021, Body temperature: 102.6 (High) for 24 hours. On 23-Apr-2021, Heart rate: inconclusive.         Treatment information was not provided. Action taken with mRNA-1273 in response to the events is not applicable   Most recent FOLLOW-UP information incorporated above includes: On 14-Jun-2021: Follow up received on 14 Jun 2021 contains No new information.
Received Pfizer vaccines on 4/18, 5/9/21 COVID-19 positive by PCR on 1/5/22 admitted to hospital on 1/5/22 for labor and delivery, delivered male infant on 1/7/22, found to be COVID positive on admission
Patient concerned about injection site reaction. Redness, hot, itchy, painful arm. reaction still there on 9/1/20
Recipient received her vaccine  and was sitting for observation when she reported feeling light headed about 5 min after the administration. 30 seconds after recipient became unresponsive and stopped breathing for 15 seconds, legs were elevated Code blue was called, after about another 30 seconds recipient  become aroused and coherent. Vitals were taken- pt. was tachycardic- 120s- came down to 80s, BP 120/80, 90% O2-eventually went up to 98%.  Temp 97.3. Med cue was called and took over to evaluate Pt. Pt. did report has had hx of vasovagal syncope.
On 06/26/2022, I was very hot and tired, but I assumed it was due to the weather. The next day I was fine, but overnight I developed a scratchy throat, chills, and a cough. That next day, Tuesday, I took an at home COVID-19 test and it was positive. After testing positive, I spoke with my doctor who prescribed antibiotics because he thought there may be an underlying bacterial infection. I had a slightly elevated temperature and was very tired and still had a scratchy throat. Wednesday, I was still tired, had a cough and scratchy throat. The rest of the week, I was very tired. I tested negative for COVID-19 on 07/10/2022 but was still experiencing fatigue. By 07/19/2022, I was feeling less tired and more normal. By the beginning of August, until around last week, I am still feeling an underlying fatigue mentally and physically. Around last Thursday, 08/11/2022, I began feeling normal again.
Left shoulder discomfort reported 11/13/08 Flu vax given 10/30/08 shoulder X-ray 11/24/08; MRI shoulder 12/4/08 Tx: Physical therapy
How long does the muscle/ ache / last /after receiving the 1st vaccine?; How long does the /joint ache / last /after receiving the 1st vaccine?; headache /last fir after receiving the 1st vaccine?; chills /last fir after receiving the 1st vaccine?; This case was reported by a consumer via media and described the occurrence of muscle pain in a patient who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received the 1st dose of Shingrix. On an unknown date, unknown after receiving Shingrix, the patient experienced muscle pain, joint pain, headache and chills. On an unknown date, the outcome of the muscle pain, joint pain, headache and chills were not recovered/not resolved.   It was unknown if the reporter considered the muscle pain, joint pain, headache and chills to be related to Shingrix.  Additional details were provided are as follows: The age at vaccination was not reported. The patient received 1st dose of Shingrix and experienced muscle/joint ache, headache and chills. The reporter asked  that how long did the muscle/joint ache, headache and chills lasted for after receiving the 1st vaccine.
patient only 17 years old, but received moderna (approved for 18 +). pt had no issues with vaccine.
Patient called about 10 days after receiving vaccine. Said her arm hurts when she bends it as crossing arms in front of herself. She says feels pulling. Hard to get dressed.